Itamar Medical (Israel) Management Performance Evaluation

ITMR -- Israel Stock  

ILS 136.40  2.20  1.59%

Analysis of Itamar Medical manpower and management performance can provide insight into Itamar Medical stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Itamar Medical future performance. Please also check Risk vs Return Analysis.

Itamar Medical Management Effectiveness

The company has return on total asset (ROA) of (15.04) % which means that it has lost $15.04 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (132.01) % meaning that it generated substantial loss on money invested by shareholders.

Itamar Medical Profit Margins

The company has Profit Margin (PM) of (21.22) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (20.93) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.21.

Itamar Medical Stakeholders

Gilad Glick CEO and Pres
Martin Gerstel Co-Chairman, Bus. Advisor, Member of Executive Committee and Member of Investment Committee
Giora Yaron Co-Chairman, Bus. Advisor and Member of Executive Committee
Ira Prigat VP and President of Itamar Medical Japan
Arnon Tuval Vice President of Operations - Itamar Medical Inc.
Joseph Tenne Vice President - Finance
Shlomo Ayanot Vice President of Operations & Engineering
Christopher Hallett Vice President of Sales - Itamar Medical Inc. - North American
Shay Basson Vice President - Finance
Efrat Litman Vice President - Research & Development
Shaul Sharoni CFO and Sr. VP
Jacob Sheffy CTO and Executive VP
Miri Katz External Director
Jonathan Kolber Director
Christopher Cleary Director
Maya TalPachter Director, Global Marketing
Shmuel Blumenfeld Director
Zipora OzerArmon External Director
Steven Ruchefsky Director
Gary Ellis Director
Sami Totah Director
Yaffa Sieradzki External Director
Yair Orgler External Director
Dafna Katz VP of Global Marketing
Eldad Singer VP of Sales Research
Daphna Triwaks Head of PR
Shahar Cohen Controller

Itamar Medical Leadership

Itamar Medical Top Executives

  Gilad Glick  CEO
CEO and Pres
  Martin Gerstel  Chairman
Co-Chairman, Bus. Advisor, Member of Executive Committee and Member of Investment Committee

Itamar Medical Tenure Analysis

Itamar Medical Employment Tenure

Itamar Medical employes about 16 people. The company is managed by 27 executives with total tenure of roughly 168 years, averanging almost 6.0 years of service per executive having 0.0 employee per reported executive.

Itamar MedicalManpower Efficiency

Return on Itamar Medical Manpower

Revenue Per Employee1.4 M
Revenue Per Executive808.5 K
Net Loss Per Employee289.4 K
Net Loss Per Executive171.5 K
Working Capital Per Employee1.8 M
Working Capital Per Executive1 M
Please also check Risk vs Return Analysis. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Search macroaxis.com